VILLA ANNAMARIA S.r.l. · 2013. 9. 24. · Department of Oncology, Villa Salaria Hospital, Rome,...
2
INFO - Organizing Secretariat: Federica Mosti - ARTOI - Tel: +39 338 1074337 - [email protected] Maria Letizia Bertollini - ARTOI - Tel: +39 338 3649983 - [email protected] Monica Brocco - ISS - Tel: 06 4990 6216 - [email protected] Press Office: LeeLoo srl +39 331 6176325 - +39 331 6158303 - [email protected] Istituto Superiore di Sanità TISNa Terapie Innovative e Sostanze Naturali Istituto Superiore di Sanità Massimo Bonucci, President, ARTOI, Rome, Italy Andrea Del Buono President, Academy of Micronutrition “Linus Pauling”, Caserta, Italy Giuseppe Di Fede Director, Institute of Biological Medicine, Milan, Italy Massimo Fioranelli Life Science Study Center, G. Marconi University, Rome, Italy Carla Fiorentini Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, Italy Andrea Geraci Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, Italy Vezia Mei Consultant, Villa Anna Maria Hospital, Rome, Italy Stefania Meschini Department of Technology and Health, ISS, Rome, Italy Agnese Molinari Department of Technology and Health, ISS, Rome, Italy Francesca Mondello Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS, Rome, Italy Annarita Stringaro Department of Technology and Health, ISS, Rome, Italy CONGRESS COORDINATORS CONGRESS VENUE Istituto Superiore di Sanità, Aula Pocchiari, Viale Regina Elena, 299 - 00161 Rome, Italy UNDER THE PATRONAGE OF Università degli Studi Guglielmo Marconi-Roma Università Cà Foscari-Venezia Bharat B. Aggarwal Department of Experimental Therapeutics, M.D. Anderson Cancer Center, Houston, TX, USA Eran Ben-Arye Integrative Oncology Program Lin Medical Center, Technion-Israel Institute of Technology, Israel Filippo Belardelli Department of Hematology, Oncology and Molecular Medicine, ISS, Rome, Italy Ettore Bergamini Research Center for Aging Biology and Pathology, University of Pisa, Italy Massimo Bonucci President of ARTOI, Rome, Italy Marco Candela Department of Pharmaceutical Sciences, University of Bologna, Italy Matteo Caleo CNR Neuroscience Institute, Pisa, Italy Massimo D’Archivio Department of Food Safety and Veterinary Public Health, ISS, Rome Gary E. Deng Integrative Medicine Service Memorial Sloan-Kettering Cancer Center, NY, USA Franco Desiderio Department of Oncology, Ospedale degli Infermi, Rimini, Italy Giuseppe Di Fede Institute of Biological Medicine, Milan, Italy Massimo Fioranelli Life Science Study Center, G. Marconi University, Rome, Italy Carla Fiorentini Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, Italy Fabio Firenzuoli Integrative Medicine Center, University of Florence, Italy Dana Flavin Founding Director of Collaborative Medicine & Research Washington DC, USA Mauro Grigioni Department of Technology and Health, ISS, Rome, Italy Jürgen-Johannes Kuehn Center of Integrative Oncology and Supportive Care, Arlesheim, Switzerland Giuseppe Lupi Acupuncture School CSTNF, Turin, Italy Stefania Meschini Department of Technology and Health, ISS, Rome, Italy Francesca Mondello Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS, Rome, Italy Giuseppe Novelli Medical Genetic Laboratory, Tor Vergata University, Rome, Italy Carlo Pastore Department of Oncology, Villa Salaria Hospital, Rome, Italy Gianluca Pazzaglia Breast Clinic Center, Perugia, Italy Alfredo Pelli Head of Viversano.com Enrico Proietti Department of Hematology, Oncology and Molecular Medicine, ISS, Rome, Italy Giampiero Ravagnan Microbiology, Cà Foscari University, Venice, Italy Giovanni Rezza Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS, Rome, Italy Pantaleo Romanelli Cyberknife Center, Centro Diagnostico Italiano (CDI), Milan, Italy and European Synchrotron Radiation Facility, Grenoble, France Elio Rossi Chief of the Homeopathy Division, Local Health Unit 2, Lucca, Italy Stephan Sagar Department of Oncology, McMaster University, Hamilton, Ontario L8S 4L8, Canada Philip A. Salem Emeritus Director Cancer Research Program St. Luke’s Episcopal Hospital, Houston, USA Annarita Stringaro Department of Technology and Health, ISS, Rome, Italy Stefano Vella Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, Italy CHAIRPERSONS AND SPEAKERS The official language of the Conference will be Italian with simultaneous Italian-English translation. For any further information please contact [email protected] or go to http://www.artoi.it OFFICIAL LANGUAGE INFORMATION Fabrizio Oleari President, Istituto Superiore di Sanità, ISS Pietro Bartolini Acting Director, Department of Technology and Health, ISS Filippo Belardelli Director, Department of Hematology, Oncology and Molecular Medicine, ISS Giovanni Rezza Director, Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS Stefano Vella Director, Department of Therapeutic Research and Medicine Evaluation, ISS Massimo Bonucci President, ARTOI, Research Association for Integrative Oncology SCIENTIFIC ADVISORY BOARD ISTITUTO SUPERIORE DI SANITÀ Department of Hematology, Oncology and Molecular Medicine Department of Infectious, Parasitic and Immune-Mediated Diseases Department of Technology and Health Department of Therapeutic Research and Medicine Evaluation ARTOI Research Association for Integrative Oncology ORGANIZED BY First ISS-ARTOI Conference on Integrative Oncology Fifth ARTOI International Congress Rome 6-7 November 2013 Istituto Superiore di Sanità AULA POCCHIARI Translational medicine: from the Laboratory to Clinical Evidence WITH THE UNCONDITIONAL SUPPORT OF VILLA ANNAMARIA S.r.l. OH INTERNATIONAL Fitoterapia Dietetica & Integratori NORFLO Graphic by Cosimo Marino Curianò
Transcript of VILLA ANNAMARIA S.r.l. · 2013. 9. 24. · Department of Oncology, Villa Salaria Hospital, Rome,...
INFO - Organizing Secretariat:Federica Mosti - ARTOI - Tel: +39 338 1074337 - [email protected]
Maria Letizia Bertollini - ARTOI - Tel: +39 338 3649983 - [email protected] Brocco - ISS - Tel: 06 4990 6216 - [email protected]
Press Office:LeeLoo srl +39 331 6176325 - +39 331 6158303 - [email protected]
Istituto Superiore di SanitàTISNa
Terapie Innovative e Sostanze Naturali
Istituto Superiore di Sanità
Massimo Bonucci, President, ARTOI, Rome, Italy
Andrea Del BuonoPresident, Academy of Micronutrition “Linus Pauling”, Caserta, ItalyGiuseppe Di Fede Director, Institute of Biological Medicine, Milan, ItalyMassimo Fioranelli Life Science Study Center, G. Marconi University, Rome, ItalyCarla Fiorentini Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, ItalyAndrea GeraciDepartment of Therapeutic Research and Medicine Evaluation, ISS, Rome, Italy
Vezia Mei Consultant, Villa Anna Maria Hospital, Rome, ItalyStefania Meschini Department of Technology and Health, ISS, Rome, ItalyAgnese Molinari Department of Technology and Health, ISS, Rome, ItalyFrancesca Mondello Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS, Rome, ItalyAnnarita Stringaro Department of Technology and Health, ISS, Rome, Italy
CONgreSS COOrdINatOrS
CONgreSS VeNueIstituto Superiore di Sanità, Aula Pocchiari, Viale Regina Elena, 299 - 00161 Rome, Italy
uNder the patrONage OF
Università degli Studi Guglielmo Marconi-RomaUniversità Cà Foscari-Venezia
Bharat B. Aggarwal Department of Experimental Therapeutics, M.D. Anderson Cancer Center, Houston, TX, USAEran Ben-Arye Integrative Oncology Program Lin Medical Center, Technion-Israel Institute of Technology, IsraelFilippo Belardelli Department of Hematology, Oncology and Molecular Medicine, ISS, Rome, ItalyEttore Bergamini Research Center for Aging Biology and Pathology, University of Pisa, ItalyMassimo Bonucci President of ARTOI, Rome, ItalyMarco Candela Department of Pharmaceutical Sciences, University of Bologna, ItalyMatteo Caleo CNR Neuroscience Institute, Pisa, ItalyMassimo D’Archivio Department of Food Safety and Veterinary Public Health, ISS, RomeGary E. Deng Integrative Medicine Service Memorial Sloan-Kettering Cancer Center, NY, USAFranco Desiderio Department of Oncology, Ospedale degli Infermi, Rimini, ItalyGiuseppe Di Fede Institute of Biological Medicine, Milan, ItalyMassimo Fioranelli Life Science Study Center, G. Marconi University, Rome, ItalyCarla Fiorentini Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, ItalyFabio Firenzuoli Integrative Medicine Center, University of Florence, ItalyDana Flavin Founding Director of Collaborative Medicine & Research Washington DC, USAMauro Grigioni Department of Technology and Health, ISS, Rome, ItalyJürgen-Johannes Kuehn Center of Integrative Oncology and Supportive Care, Arlesheim, Switzerland
Giuseppe Lupi Acupuncture School CSTNF, Turin, ItalyStefania Meschini Department of Technology and Health, ISS, Rome, ItalyFrancesca Mondello Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS, Rome, ItalyGiuseppe Novelli Medical Genetic Laboratory, Tor Vergata University, Rome, ItalyCarlo Pastore Department of Oncology, Villa Salaria Hospital, Rome, ItalyGianluca Pazzaglia Breast Clinic Center, Perugia, ItalyAlfredo Pelli Head of Viversano.comEnrico Proietti Department of Hematology, Oncology and Molecular Medicine, ISS, Rome, ItalyGiampiero Ravagnan Microbiology, Cà Foscari University, Venice, ItalyGiovanni Rezza Department of Infectious, Parasitic and Immune-Mediated Diseases, ISS, Rome, ItalyPantaleo Romanelli Cyberknife Center, Centro Diagnostico Italiano (CDI), Milan, Italy and European Synchrotron Radiation Facility, Grenoble, FranceElio Rossi Chief of the Homeopathy Division, Local Health Unit 2, Lucca, ItalyStephan Sagar Department of Oncology, McMaster University, Hamilton, Ontario L8S 4L8, CanadaPhilip A. Salem Emeritus Director Cancer Research Program St. Luke’s Episcopal Hospital, Houston, USAAnnarita Stringaro Department of Technology and Health, ISS, Rome, Italy Stefano Vella Department of Therapeutic Research and Medicine Evaluation, ISS, Rome, Italy
ChaIrperSONS aNd SpeakerS
The official language of the Conference will be Italian with simultaneous Italian-English translation.
For any further information please contact [email protected] or go to http://www.artoi.it
OFFICIal laNguage INFOrmatION
Fabrizio Oleari President, Istituto Superiore di Sanità, ISS Pietro Bartolini Acting Director, Department of Technology and Health, ISS Filippo Belardelli Director, Department of Hematology, Oncology and Molecular Medicine, ISS
Giovanni Rezza Director, Department of Infectious, Parasitic and Immune-Mediated Diseases, ISSStefano Vella Director, Department of Therapeutic Research and Medicine Evaluation, ISSMassimo Bonucci President, ARTOI, Research Association for Integrative Oncology
SCIeNtIFIC adVISOry BOard
ISTITUTO SUPERIORE DI SANITàDepartment of Hematology,
Oncology and Molecular MedicineDepartment of Infectious,
Parasitic and Immune-Mediated DiseasesDepartment of Technology and Health
Department of Therapeutic Research and Medicine Evaluation
ARTOIResearch Association for Integrative Oncology
ORgANIzED by
First ISS-ARTOI Conference on Integrative Oncology Fifth ARTOI International Congress
Rome 6-7 November 2013 Istituto Superiore di Sanità
AUlA POCChIARI
Translational medicine: from the Laboratory to Clinical Evidence
WIth the uNCONdItIONal SuppOrt OF
Il Benessere del Paziente è Il Nostro Obiettivo
IL III CONGRESSO INTERNAZIONALE DI
"TERAPIA ONCOLOGICA INTEGRATA "SI TERRÀ A ROMA IL 2 E 3 DICEMBRE 2011,
VENERDI 2/12/2011: Presso La Camera Dei Deputati
Seduta Plenaria
SABATO 3/12/2011 Presso Hotel Boscolo Exedra Roma
MATTINA: Casistiche Internazionali
POMERIGGIO: I WORKSHOP INTERNAZIONALE “NUTRIZIONE IN ONCOLOGIA"
I NOSTRI OBIETTIVI:
* La Cura del Paziente. Il nostro impegno è la salvaguardia dell’individuo in quanto persona. Non dobbiamo curare la malattia, ma la persona affetta dalla malattia. Ecco che il nostro impegno si sposta sul paziente. Dobbiamo interagire al meglio e comprendere il suo disagio.
* La Divulgazione delle Scoperte Scientifiche, siano esse di carattere farmacologico che metodologico, l’acquisizione e sostegno per lo sviluppo di nuovi protocolli; la nascita o l’individuazione di Centri atti all’applicazione degli stessi.
* La Prevenzione e la Protezione dei pazienti a rischio o già colpiti da neoplasia. Proteggere significa ridurre degli effetti collaterali delle terapie antiblastiche. Proteggere significa anche ridurre la probabilità di ricadute della patologia neoplastica (metastatizzazione). Prevenzione significa ridurre il rischio di ammalarsi di tumore, vivere una vita più serena, acquisire conoscenze che migliorano la nostra salute.
Seg re t e r i a A .R .T .O . I . +39 333 2654900 Seg re t e r i a FOEDUS + 39 345 6940048
www.a r t o i . i t
i n f o@ar to i . i t
i n f o@fondaz i one foed us .o rg
U f f i c i o S t ampa : NEWMAN D r . ssa Luc i l l a Vazza +39 338 1823193
s p o n s o r :
LA LINGUA UFFICIALE DEL CONGRESSO SARÀ L'ITALIANOCON TRADUZIONE SIMULTANEA IN INGLESE
III CONGRESSO INTERNAZIONALE DI ONCOLOGIA INTEGRATA
Ricerca, Trattamenti ed Evidenza Clinica
ROMA 2-3 Dicembre
CAMERA DEI DEPUTATI
Siamo arrivati al nostro 3° Congresso internazionale di Oncologia Integrata. La ricerca di base, i trattamenti integrati, la farmacogenomica e le novità farmaceutiche sono la nostra realtà ed il nostro scopo. Abbiamo voluto dare un ulteriore segno dell’indirizzo scientifico dedicando una sessione del Sabato 3 Dicembre alla Casistica Internazionale.
Al Congresso hanno aderito numerosi Colleghi Internazionali provenienti daStati Uniti, Argentina, Spagna, Israele, Olanda, Giappone e Cina, contribuendo allo sviluppo di una conoscenza medica integrata e una realtà di network internazionale di Oncologia Integrata.
Questo III° Congresso riserverà anche una importante sessione dedicata alla “Nutrizione in Oncologia” con la realizzazione di un Workshop, per pazienti ed operatori sanitari.L’evento si svolgerà in una sede istituzionale e vedrà la partecipazione di professionisti qualificati, sia medici oncologi che nutrizionisti, coadiuvati dai più importanti esperti del settore agroalimentare, fra i quali spiccano chef ed antropologi.
Spero che dal Congresso possiate ricavare una conoscenza più approfondita delle tematiche di integrazione in Oncologia oltre ad acquisire esperienza e pratica clinica dai consigli dei Colleghi presenti.
Vi aspetto numerosi
Dr. Massimo BONUCCIPresidente A.R.T.O.I.Presidente III° CONGRESSO INTERNAZIONALE DI ONCOLOGIA INTEGRATA
Ricerca - Trattamenti - Evidenze Cliniche
III Congresso InternazionaleTERAPIA ONCOLOGICA INTEGRATA
Comitato Scientifico: Massimo Bonucci M.D. - Giuseppe Di Fede M.D.Massimo Fioranelli M.D. - Vezia Mei M.D. - Beniamino Palmieri M.D.Carlo Pastore M.D.
Il Corso è in fase di accreditamento ECM per medici e nutrizionisti, presso il Ministero della Salute.-----------------------------------------------------------------------------------Patrocini:A.R.T.O.I. - FOEDUS - AIMAC - Università di MILANO - Università G.MARCONI - Università degli Studii di MODENA E REGGIO EMILIA - ASSIE
COLLABORATING CENTREFOR TRADITIONAL MEDICINE
dell’Università degli Studi di Milano
WORLD HEALTH ORGANIZATION
ROMA2-3 Dicembre 2011Sala del le ConferenzeCAMERA DEI DEPUTATIPalazzo MariniVia del Pozzetto, 158
VILLA ANNAMARIA S.r.l.
oh internationalFitoterapia Dietetica & integratori
NORFLO
Gra
phic
by C
osim
o M
arin
o C
uria
nò
WedNeSday, NOVemBer 6
9.00 Registration
9.30 Opening Ceremony Fabrizio Oleari, Massimo Bonucci,
Pietro Bartolini, Filippo Belardelli, Giovanni Rezza, Stefano Vella
CaNCer preVeNtION
Chairs: Carla Fiorentini, Stephan Sagar
Keynote Lecture
10.00 The dynamics of the multidisciplinary approach in cancer treatment
Philip A. Salem
10.30 Coffee Break
11.00 Diet restriction and cancer Ettore Bergamini
11.20 Diet, intestinal microbiome and colorectal cancer onset
Marco Candela
11.40 Pap-breast: innovative method for prevention of breast cancer
Gianluca Pazzaglia
12.00 Dietary fatty acid and adipose tissue function in colon cancer
Massimo D’Archivio
12.20 Discussion 13.00 Lunch and poster session
INtegratIVe ONCOlOgy reSearCh
Chairs: Giampiero Ravagnan, Filippo Belardelli
14.30 Multi-targeting of multigenic cancer by nutraceuticals: role in prevention and treatment
Bharat B. Aggarwal
14.50 Natural alkaloid products: drug discovery and therapeutic optimization
Stefania Meschini
15.10 Potential therapeutic activity of tea tree oil and its main component, terpinen-4-ol, against mucocutaneous candidosis in oncological patients
Francesca Mondello
15.30 Antitumor activity of aloe-emodin in breast cancer cells
Annarita Stringaro
15.50 Discussion
16.10 Coffee break and poster session
16.30 The frontiers of radiosurgery. From the CyberKnife to Synchrotron
Pantaleo Romanelli
16.55 Oncogenomics and personalized medicine
Giuseppe Novelli
17.15 Discussion
19.30 Gala dinner
thurSday, NOVemBer 7
INtegratIVe therapy IN ONCOlOgy
Chairs: Massimo Fioranelli, Stefano Vella
9.00 Acupuncture in cancer care: the US experience
Gary E. Deng
9.20 Integrative medicine approach to palliative care improvement
Eran Ben-Arye
9.40 The bacterial protein toxin CNF1 prolongs survival in a mouse model of glioma
Matteo Caleo
10.00 Discussion
10.30 Coffee Break
11.00 Patient-centred integrative care: what are the challenges?
Stephan Sagar
11.20 Natural products and drug vigilance
Fabio Firenzuoli
11.40 Novel strategies for combining immunotherapy with chemotherapy:
from the preclinical studies to the clinical experimentation
Enrico Proietti
12.00 Discussion
12.30 Lunch and poster session
AimsThe primary aim of this conference is to devote two days to the study, the research and the application of cancer treatments through the integrative use of multiple therapeutic options. Conference participants will gain knowledge in: i) cancer prevention, with particular regard to nutrition, immune system and microbiome; ii) research on the use of new molecules, implementation of new methods of drug administration, and integration of different treatment methods; iii) results obtained in clinical studies on the administration of cancer treatments through the integrative use of different therapeutic options.
INtegratIVe apprOaCh tO CaNCer Care: CaSe StudIeS
Chairs: Giuseppe Di Fede, Giovanni Rezza
14.00 Nanoparticle-mediated delivery: crossing intracellular and cellular barriers
Dana Flavin
14.15 Integrative treatments in cancer patients: clinical research on mistletoe and cancer: personal experience
Jürgen-Johannes Kuehn
14.25 Acupuncture as a complementary therapy for chemotherapy side effects:
the experience of a Public Health Service in Aosta Valley Autonomous Region
Giuseppe Lupi
14.35 The Salem’s program cancer treatment: multidisciplinary approach
Philip A. Salem
14.50 Treatment of menopausal symptoms in cancer breast disease free patients:
clinical trial randomized double-blind
Franco Desiderio
15.00 Integrative acupuncture in cancer patients: personal cases
Gary Deng
15.15 Integrative treatments in cancer patients: case studies
Massimo Bonucci, Carlo Pastore
15.30 Homeopathy and nutrition in Oncology: experience of homeopathy
Outpatient clinic - Regional structure of reference USL 2 Lucca
Elio Rossi
15.40 Best Contributed Poster presentations
15.50 The digital medical record and videoconference for the patient:
just a click away for integrative consulting
Alfredo Pelli
16.00 Care models and Information and Communication Technology in favour of long-term survivors
Mauro Grigioni
16.15 Closing remarks
